Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability

Acta Med Austriaca. 1989;16(3-4):70-3.

Abstract

In a group of 31 patients a port-a-cath-system for intraperitoneal chemotherapy was installed. From 23 evaluable patients 9 showed a tumor remission, but only 1 was a patient with gastrointestinal carcinoma. All others were patients with ovarial carcinoma. The median survival rate of all patients was 9 months after implantation of the intraperitoneal catheter. 50% of all patients with gastrointestinal carcinoma died within the first 6 months, only 1 of 11 patients with ovarial carcinoma died in this period.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin
  • Catheters, Indwelling
  • Cisplatin / administration & dosage
  • Critical Care*
  • Drug Evaluation
  • Female
  • Fluorouracil / administration & dosage*
  • Follow-Up Studies
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Ovarian Neoplasms / drug therapy*
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / secondary*
  • Retrospective Studies

Substances

  • Organoplatinum Compounds
  • Carboplatin
  • Cisplatin
  • Fluorouracil